BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22878685)

  • 1. Lys05: a new lysosomal autophagy inhibitor.
    Amaravadi RK; Winkler JD
    Autophagy; 2012 Sep; 8(9):1383-4. PubMed ID: 22878685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.
    McAfee Q; Zhang Z; Samanta A; Levi SM; Ma XH; Piao S; Lynch JP; Uehara T; Sepulveda AR; Davis LE; Winkler JD; Amaravadi RK
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8253-8. PubMed ID: 22566612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma.
    Zhou W; Guo Y; Zhang X; Jiang Z
    J Cell Biochem; 2020 Feb; 121(2):2027-2037. PubMed ID: 31642111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
    Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
    Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma.
    DeVorkin L; Hattersley M; Kim P; Ries J; Spowart J; Anglesio MS; Levi SM; Huntsman DG; Amaravadi RK; Winkler JD; Tinker AV; Lum JJ
    Mol Cancer Res; 2017 Mar; 15(3):250-258. PubMed ID: 28184014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation.
    Gustafson DL; Viola LO; Towers CG; Das S; Duval DL; Van Eaton KM
    Vet Comp Oncol; 2023 Dec; 21(4):726-738. PubMed ID: 37724007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
    Rebecca VW; Nicastri MC; Fennelly C; Chude CI; Barber-Rotenberg JS; Ronghe A; McAfee Q; McLaughlin NP; Zhang G; Goldman AR; Ojha R; Piao S; Noguera-Ortega E; Martorella A; Alicea GM; Lee JJ; Schuchter LM; Xu X; Herlyn M; Marmorstein R; Gimotty PA; Speicher DW; Winkler JD; Amaravadi RK
    Cancer Discov; 2019 Feb; 9(2):220-229. PubMed ID: 30442709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells.
    Zhao X; Fang Y; Yang Y; Qin Y; Wu P; Wang T; Lai H; Meng L; Wang D; Zheng Z; Lu X; Zhang H; Gao Q; Zhou J; Ma D
    Autophagy; 2015; 11(10):1849-63. PubMed ID: 25893854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.
    Piao S; Ojha R; Rebecca VW; Samanta A; Ma XH; Mcafee Q; Nicastri MC; Buckley M; Brown E; Winkler JD; Gimotty PA; Amaravadi RK
    Autophagy; 2017; 13(12):2056-2071. PubMed ID: 28981387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.
    Guntuku L; Gangasani JK; Thummuri D; Borkar RM; Manavathi B; Ragampeta S; Vaidya JR; Sistla R; Vegi NGM
    Oncogene; 2019 Jan; 38(4):581-595. PubMed ID: 30166591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drain the lysosome: Development of the novel orally available autophagy inhibitor ROC-325.
    Carew JS; Nawrocki ST
    Autophagy; 2017 Apr; 13(4):765-766. PubMed ID: 28118053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroquine, the next generation antimalarial drug, has antitumor activity.
    Kondratskyi A; Kondratska K; Vanden Abeele F; Gordienko D; Dubois C; Toillon RA; Slomianny C; Lemière S; Delcourt P; Dewailly E; Skryma R; Biot C; Prevarskaya N
    Sci Rep; 2017 Nov; 7(1):15896. PubMed ID: 29162859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lys05 - A Promising Autophagy Inhibitor in the Radiosensitization Battle: Phosphoproteomic Perspective.
    Ondrej M; Cechakova L; Fabrik I; Klimentova J; Tichy A
    Cancer Genomics Proteomics; 2020; 17(4):369-382. PubMed ID: 32576582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis.
    Carew JS; Espitia CM; Zhao W; Han Y; Visconte V; Phillips J; Nawrocki ST
    Clin Cancer Res; 2017 Jun; 23(11):2869-2879. PubMed ID: 27881580
    [No Abstract]   [Full Text] [Related]  

  • 15. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
    Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress of hydroxychloroquine and autophagy inhibitors on cancer.
    Shi TT; Yu XX; Yan LJ; Xiao HT
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):287-294. PubMed ID: 27889812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
    Zhang L; Qiang P; Yu J; Miao Y; Chen Z; Qu J; Zhao Q; Chen Z; Liu Y; Yao X; Liu B; Cui L; Jing H; Sun G
    Autophagy; 2019 Mar; 15(3):391-406. PubMed ID: 30145925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.
    Ndoye A; Budina-Kolomets A; Kugel CH; Webster MR; Kaur A; Behera R; Rebecca VW; Li L; Brafford PA; Liu Q; Gopal YNV; Davies MA; Mills GB; Xu X; Wu H; Herlyn M; Nicastri MC; Winkler JD; Soengas MS; Amaravadi RK; Murphy ME; Weeraratna AT
    Cancer Res; 2017 Nov; 77(21):5873-5885. PubMed ID: 28887323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.
    Ferreira PMP; Sousa RWR; Ferreira JRO; Militão GCG; Bezerra DP
    Pharmacol Res; 2021 Jun; 168():105582. PubMed ID: 33775862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antitumour strategy using bidirectional autophagic vesicles accumulation via initiative induction and the terminal restraint of autophagic flux.
    Wang Y; Tai X; Zhang L; Liu Y; Gao H; Chen J; Shi K; Zhang Q; Zhang Z; He Q
    J Control Release; 2015 Feb; 199():17-28. PubMed ID: 25499918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.